Please assess the completion status of the following clinical trial:

Trial Title: Immune Activation as a Cause of Insulin Resistance in Adults Living With HIV-1 on Effective Antiretroviral Therapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Subject consulting or hospitalized in the tropical and infectious diseases unit at the University Hospital of Montpellier that have been enrolled in a study during which the immune activation profile was analyzed~* Subject aged at least 18 years~* Subject speaking french fluently~* Subject who is not opposed to participate to the study, after a clear information~* Subject affiliated to a social security system~* Infection by HIV-1 determined by a positive serology or by a measure of the plasma viral load (RNA HIV)~* HIV-1 patients under stable antiretroviral therapy~* HIV load \< 50 copies/mL since at least 6 months before enrollment (2 measures)~Exclusion criteria:~* Vulnerable individuals~* Persons protected~* Pregnant women or breastfeeding mothers~* Bad understanding of the nature and goals of the study and/or communication difficulties with the investigator~* Subject enrolled in an other study with an exclusion period still running~* Non infectious pathology that might be the origin of an immune anomaly~* Treatment by an immune modulator molecule or by chemotherapy in the 60 days before enrollment in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Non viremic HIV patients under treatment (Type: None): Patients with various immune activation profiles

Based on this trial design, predict the completion outcome and termination type (if applicable).